Real-world patient characteristics and clinical outcomes in patients with myelofibrosis in Japan.
Saved in:
| Title: | Real-world patient characteristics and clinical outcomes in patients with myelofibrosis in Japan. |
|---|---|
| Authors: | Yasutomi Y; Medical Affairs, GSK, Tokyo, Japan., Takano M; Real World Data Analytics, GSK, Tokyo, Japan., Chen YC; Value Evidence & Outcomes APAC, GSK, Singapore, Singapore., Chen CC; Real World Evidence Solutions, IQVIA, Wayne, United States of America., Kim SW; Real World Evidence Solutions, IQVIA, Tokyo, Japan., McGuiness C; Health Economics and Outcomes Research, Real World Evidence, IQVIA, Wayne, United States of America., Slowley A; Global Value Evidence and Outcomes (VEO), GSK, London, United Kingdom., Kirito K; Department of Hematology/Oncology, University of Yamanashi, Yamanashi, Japan. |
| Source: | PloS one [PLoS One] 2026 May 08; Vol. 21 (5), pp. e0348598. Date of Electronic Publication: 2026 May 08 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1932-6203 |
|---|---|
| DOI: | 10.1371/journal.pone.0348598 |
